Medically treated emphysematous gastritis in a patient with rheumatoid arthritis: report of case

Year 2021, , 111 - 113, 14.12.2021

Cemal Ulusoy Andrej Nikolovski Tuba Saydam

https://doi.org/10.33706/jemcr.949264

Abstract

Emphysematous gastritis is rare infection of the gastric wall associated with high mortality. Damage of the gastric mucosal barrier and bacterial translocation can lead to emphysematous gastritis. Non-steroidal anti-inflammatory drugs use is one of the etiological factors. Due to the high mortality rates, early diagnosis and treatment is important. Patients are presenting to emergency departments generally with non-specific acute abdominal signs. We present a case of an 82 years old patient with rheumatoid arthritis treated with non-steroidal anti-inflammatory drug that presented to the emergency department with diffuse abdominal pain, nausea and vomiting. After establishing the diagnosis, conservative treatment was conducted with success.

Keywords

emphysematous gastritis, medical treatment, rheumatoid arthritis

References

• Nemakayala DR, Rai MP, Rayamajhi S, Jafri SM. Role of Conservative Management In Emphysematous Gastritis. BMJ Case Rep. 2018; 2018:bcr2017222118. Published 2018 Feb 23. doi: 10.1136/bcr-2017-222118
• Watson A, Bul V, Staudacher J, Carroll R, Yazici C. The predictors of mortality and secular changes in management strategies in emphysematous gastritis. Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):e1-e7. doi: 10.1016/j.clinre.2016.02.011. Epub 2016 Jun 20. PMID: 27339595
• Watson A, Bul V, Staudacher J, Carroll R, Yazici C. The predictors of mortality and secular changes in management strategies in emphysematous gastritis. Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):e1-e7. doi: 10.1016/j.clinre.2016.02.011. Epub 2016 Jun 20. PMID: 27339595